期刊
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
卷 138, 期 -, 页码 324-339出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.techfore.2018.10.012
关键词
Knowledge dynamics; Emerging technologies; Stem cell therapies; Cell transplantations; Knowledge structures; Clinical practices
资金
- MEXT/JSPS World Premier International Research Center (WPI) Initiative
- MEXT/JSPS Kakenhi [26301022, 16K17165]
- Organisation in Transition Research Cluster, University of Exeter Business School, University of Exeter, UK [1-SC-C-N68-242-USC01-SSC31-A355-PZSC177]
- Grants-in-Aid for Scientific Research [16K17165, 26301022] Funding Source: KAKEN
Newly emerging therapeutic technologies have the potential to reconfigure the understanding, diagnosis, and treatment of diseases, and, consequently, to impact human health. This study integrates co-evolutionary and system-oriented perspectives to investigate factors influencing the way emerging therapies evolve in their attempt to become established medical practices. We examined the case of the use of induced pluripotent stem (iPS) cell-based therapies for age-related macular degeneration (AMD) disease. Cell therapy evolution is explored by considering their constitutive components, namely disease, biomedical technologies, and clinical practices, and observing the changes experienced by their underlying knowledge structures. We adopted a mixed methods approach that simultaneously uses publication, patent, and clinical trial data. Our results highlight the significance of the diversity of technological possibilities, the role of subjective issues in the selection of directions of search, the complementary nature between established and emerging therapies, and the tight product-process interdependencies. This study contributes to an understanding of the difficulties encountered during the emergence of new cell therapies, and the ways in which such difficulties can be circumvented to establish effective and safe cell-based clinical practices.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据